Evidence map›Paper›PMID 31277718›Full record

ArticleOrphanet journal of rare diseases2019

Genomic imbalances defining novel intellectual disability associated loci.

Fátima Lopes, Fátima Torres, Gabriela Soares, Mafalda Barbosa, João Silva, Frederico Duque, Miguel Rocha, Joaquim Sá, Guiomar Oliveira, Maria João Sá and 32 more

Open access · goldAbstract read
In one paragraph

Article in Orphanet journal of rare diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

42 authors at 16 institutions in 4 countries.

Fátima LopesLife and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057, Braga, Portugal.
Fátima TorresCGC Genetics, Porto, Portugal.
Gabriela SoaresCenter for Medical Genetics Dr. Jacinto Magalhães, Porto Hospital Center, Praça Pedro Nunes, Porto, Portugal.
Mafalda BarbosaCenter for Medical Genetics Dr. Jacinto Magalhães, Porto Hospital Center, Praça Pedro Nunes, Porto, Portugal.
João SilvaCenter for Medical Genetics Dr. Jacinto Magalhães, Porto Hospital Center, Praça Pedro Nunes, Porto, Portugal.
Frederico DuqueUnidade de Neurodesenvolvimento e Autismo do Serviço do Centro de Desenvolvimento da Criança and Centro de Investigação e Formação Clínica, Pediatric Hospital, Centro Hospitalar e Universitário de Coimbra, 3041-80, Coimbra, Portugal.
Miguel RochaCenter for Medical Genetics Dr. Jacinto Magalhães, Porto Hospital Center, Praça Pedro Nunes, Porto, Portugal.
Joaquim SáCGC Genetics, Porto, Portugal.
Guiomar OliveiraUnidade de Neurodesenvolvimento e Autismo do Serviço do Centro de Desenvolvimento da Criança and Centro de Investigação e Formação Clínica, Pediatric Hospital, Centro Hospitalar e Universitário de Coimbra, 3041-80, Coimbra, Portugal.
Maria João SáCenter for Medical Genetics Dr. Jacinto Magalhães, Porto Hospital Center, Praça Pedro Nunes, Porto, Portugal.
Teresa TemudoPediatric Neurology Department, Centro Materno-Infantil Centro Hospitalar do Porto, Porto, Portugal.
Susana SousaLife and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057, Braga, Portugal.
Carla MarquesUnidade de Neurodesenvolvimento e Autismo do Serviço do Centro de Desenvolvimento da Criança and Centro de Investigação e Formação Clínica, Pediatric Hospital, Centro Hospitalar e Universitário de Coimbra, 3041-80, Coimbra, Portugal.
Sofia LopesLife and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057, Braga, Portugal.
Catarina GomesLife and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057, Braga, Portugal.
Gisela BarrosLife and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057, Braga, Portugal.
Arminda JorgeDevelopment Unit, Pediatrics Service, Hospital Centre of Cova da Beira, Covilhã, Portugal.
Felisbela RochaDepartment of Pediatrics, Médio Ave Hospital Center, Vila Nova de Famalicão, Portugal.
Cecília MartinsDepartment of Pediatrics, Médio Ave Hospital Center, Vila Nova de Famalicão, Portugal.
Sandra MesquitaDevelopment Unit, Pediatrics Service, Hospital Centre of Cova da Beira, Covilhã, Portugal.
Susana LoureiroDepartment of Pediatrics, Hospital S. Teotónio, Tondela/Viseu Hospital Center, Viseu, Portugal.
Elisa Maria CardosoDepartment of Pediatrics, Hospital S. Teotónio, Tondela/Viseu Hospital Center, Viseu, Portugal.
Maria José CálixDepartment of Pediatrics, Hospital S. Teotónio, Tondela/Viseu Hospital Center, Viseu, Portugal.
Andreia DiasDepartment of Pediatrics, Hospital S. Teotónio, Tondela/Viseu Hospital Center, Viseu, Portugal.
Cristina MartinsNeuropaediatric Unit - Garcia de Orta Hospital, Almada, Portugal.
Céu R MotaPediatric and Neonatal Intensive Care, Department of Pediatrics, Porto Hospital Center, Porto, Portugal.
Diana AntunesDepartment of Genetics, Hospital D. Estefânia, Lisboa-Norte Hospital Center, Lisbon, Portugal.
Juliette DupontGenetics Service, Paediatric Department, University Hospital Santa Maria, Lisbon, Portugal.
Sara FigueiredoDepartment of Pediatrics, Médio Ave Hospital Center, Santo Tirso, Portugal.
Sónia FigueiroaDivision of Pediatric Neurology, Department of Child and Adolescent, Centro Hospitalar do Porto e Hospital de Santo António, Porto, Portugal.
Susana Gama-de-SousaDepartment of Pediatrics, Médio Ave Hospital Center, Vila Nova de Famalicão, Portugal.
Sara CruzNeuropsychophysiology Lab, CIPsi, School of Psychology, University of Minho, Braga, Portugal.
Adriana SampaioNeuropsychophysiology Lab, CIPsi, School of Psychology, University of Minho, Braga, Portugal.
Paul EijkDepartment of Pathology, VU University Medical Center, Amsterdam, 1007, MB, The Netherlands.
Marjan M WeissDepartment of Clinical Genetics, VU University Medical Center, Amsterdam, 1007, MB, The Netherlands.
Bauke YlstraDepartment of Pathology, VU University Medical Center, Amsterdam, 1007, MB, The Netherlands.
Paula RendeiroCGC Genetics, Porto, Portugal.
Purificação TavaresCGC Genetics, Porto, Portugal.
Margarida Reis-LimaCenter for Medical Genetics Dr. Jacinto Magalhães, Porto Hospital Center, Praça Pedro Nunes, Porto, Portugal.
Jorge Pinto-BastoCGC Genetics, Porto, Portugal.
Ana Maria FortunaCenter for Medical Genetics Dr. Jacinto Magalhães, Porto Hospital Center, Praça Pedro Nunes, Porto, Portugal.
Patrícia MacielLife and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057, Braga, Portugal. pmaciel@med.uminho.pt.ORCID 0000-0002-0920-6350
University of Minho · PTCentro de Genética Clínica · PTHospital São Teotónio · PTAmsterdam UMC Location Vrije Universiteit Amsterdam · NLHospitais da Universidade de Coimbra · PTUniversidade do Porto · PTHospital de Santo António · PTHospital Garcia de Orta · PTCentro Hospitalar do Porto · PTCUF Porto Hospital · PTHospital Braga · PTHospital Center of Cova da Beira · PTHospital de Dona Estefânia · PTHospital de Santa Maria · PTSynlab Czech (Czechia) · CZUniversity of Beira Interior · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHigh resolution genome-wide copy number analysis, routinely used in clinical diagnosis for several years, retrieves new and extremely rare copy number variations (CNVs) that provide novel candidate genes contributing to disease etiology. The aim of this work was to identify novel genetic causes of neurodevelopmental disease, inferred from CNVs detected by array comparative hybridization (aCGH), in a cohort of 325 Portuguese patients with intellectual disability (ID).

resultsWe have detected CNVs in 30.1% of the patients, of which 5.2% corresponded to novel likely pathogenic CNVs. For these 11 rare CNVs (which encompass novel ID candidate genes), we identified those most likely to be relevant, and established genotype-phenotype correlations based on detailed clinical assessment. In the case of duplications, we performed expression analysis to assess the impact of the rearrangement. Interestingly, these novel candidate genes belong to known ID-related pathways. Within the 8% of patients with CNVs in known pathogenic loci, the majority had a clinical presentation fitting the phenotype(s) described in the literature, with a few interesting exceptions that are discussed.

conclusionsIdentification of such rare CNVs (some of which reported for the first time in ID patients/families) contributes to our understanding of the etiology of ID and for the ever-improving diagnosis of this group of patients.

Indexed as

Chromosome AberrationsComparative Genomic HybridizationDNA Copy Number VariationsFemaleGenetic Association StudiesGenomicsHistone-Lysine N-MethyltransferaseHumansIntellectual DisabilityMalePedigreePhenotypeEHMT1 protein, humanHistone-Lysine N-MethyltransferaseCNVsCUL4B overexpressionGenotype-phenotype correlationNeurodevelopment

Identifiers

PMID31277718
PMCPMC6612161
OpenAlexW2953410154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.